DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.
Revenue of DSM-Firmenich AG (DSFIR.AS)
Revenue in 2023 (TTM): $11.55 B
According to DSM-Firmenich AG's latest financial reports the company's current revenue (TTM) is $11.55 B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of DSM-Firmenich AG
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $11.55 B | $3.49 B | $1.43 B | $-703,142,451 | $-708,576,319 |
| 2022 | $9.12 B | $3.02 B | $1.5 B | $645.54 M | $499.92 M |
| 2021 | $12.44 B | $4.55 B | $933.54 M | $700.97 M | $947.67 M |
| 2020 | $8.81 B | $3.02 B | $1.31 B | $611.85 M | $486.87 M |
| 2019 | $8.69 B | $3 B | $1.4 B | $906.37 M | $733.57 M |
| 2018 | $10.07 B | $3.7 B | $1.81 B | $1.38 B | $1.16 B |
| 2017 | $9.38 B | $3.19 B | $1.36 B | $2.06 B | $1.91 B |
| 2016 | $8.61 B | $2.89 B | $1.17 B | $810.73 M | $700.97 M |
| 2015 | $8.39 B | $2.51 B | $899.85 M | $247.78 M | $189.1 M |
| 2014 | $7.66 B | $2.44 B | $1.11 B | $178.23 M | $133.67 M |
| 2013 | $9.63 B | $2.67 B | $1.32 B | $366.24 M | $273.87 M |